| Product Code: ETC7647439 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continued to rely on imports of cardioselective beta blockers, with top exporters being Switzerland, UK, Belgium, USA, and Germany. The market showed low concentration levels with a low Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) for 2020-2024 was -2.14%, indicating a slight decline in demand. The growth rate from 2023 to 2024 further decreased by -0.41%, suggesting a challenging market environment for cardioselective beta blockers in Israel. Continued monitoring and strategic adjustments may be necessary for stakeholders in this market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cardioselective Beta Blockers Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cardioselective Beta Blockers Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cardioselective Beta Blockers Market - Industry Life Cycle |
3.4 Israel Cardioselective Beta Blockers Market - Porter's Five Forces |
3.5 Israel Cardioselective Beta Blockers Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Israel Cardioselective Beta Blockers Market Revenues & Volume Share, By Target, 2021 & 2031F |
3.7 Israel Cardioselective Beta Blockers Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Israel Cardioselective Beta Blockers Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Israel Cardioselective Beta Blockers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Israel |
4.2.2 Growing awareness about the benefits of cardioselective beta blockers in managing heart conditions |
4.2.3 Technological advancements leading to the development of improved cardioselective beta blockers |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for cardiovascular drugs in Israel |
4.3.2 Competition from alternative treatment options for cardiovascular diseases |
5 Israel Cardioselective Beta Blockers Market Trends |
6 Israel Cardioselective Beta Blockers Market, By Types |
6.1 Israel Cardioselective Beta Blockers Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Angina, 2021- 2031F |
6.1.4 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Hypertension, 2021- 2031F |
6.1.5 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Heart Failure, 2021- 2031F |
6.1.6 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Arrhythmias, 2021- 2031F |
6.1.7 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Cardioselective Beta Blockers Market, By Target |
6.2.1 Overview and Analysis |
6.2.2 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Beta-1 Receptors, 2021- 2031F |
6.2.3 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Beta-2 Receptors, 2021- 2031F |
6.2.4 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Cardioselective Beta Blockers Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Betaxolol, 2021- 2031F |
6.3.3 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Acebutolol, 2021- 2031F |
6.3.4 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Esmolol, 2021- 2031F |
6.3.5 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Atenolol, 2021- 2031F |
6.3.6 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Cardioselective Beta Blockers Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Israel Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Cardioselective Beta Blockers Market Import-Export Trade Statistics |
7.1 Israel Cardioselective Beta Blockers Market Export to Major Countries |
7.2 Israel Cardioselective Beta Blockers Market Imports from Major Countries |
8 Israel Cardioselective Beta Blockers Market Key Performance Indicators |
8.1 Number of clinical trials and research studies on cardioselective beta blockers in Israel |
8.2 Adoption rate of cardioselective beta blockers among healthcare providers in Israel |
8.3 Patient adherence and compliance rates with cardioselective beta blocker treatment plans in Israel |
9 Israel Cardioselective Beta Blockers Market - Opportunity Assessment |
9.1 Israel Cardioselective Beta Blockers Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Israel Cardioselective Beta Blockers Market Opportunity Assessment, By Target, 2021 & 2031F |
9.3 Israel Cardioselective Beta Blockers Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Israel Cardioselective Beta Blockers Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Israel Cardioselective Beta Blockers Market - Competitive Landscape |
10.1 Israel Cardioselective Beta Blockers Market Revenue Share, By Companies, 2024 |
10.2 Israel Cardioselective Beta Blockers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here